The efficacy and feasibility of weekly 5-FU and cisplatin based radical concurrent chemoradiation therapy(CRT) in patients with esophageal cancer.

被引：0
|
作者：
Jeong, Joon Won
Yang, Ji Hyun
Ro, Sang Mi
Kim, In-Ho
Roh, Sang Young
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Div Med Oncol, Dept Internal Med, Seoul, South Korea
[2] Seoul St Marys Hosp, Div Oncol, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
169
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer:Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine
    Hyung-SikLee
    YoungminChoi
    Won-JooHur
    Hyo-JinKim
    Hyuk-ChanKwon
    Sung-HyunKim
    Jae-SeokKim
    Jong-Hoon Lee
    Ghap-JoongJung
    Min-ChanKim
    World Journal of Gastroenterology, 2006, (04) : 603 - 607
  • [32] Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine
    Lee, Hyung-Sik
    Choi, Youngmin
    Hur, Won-Joo
    Kim, Hyo-In
    Kwon, Hyuk-Chan
    Kim, Sung-Hyun
    Kim, Jae-Seok
    Lee, Jong-Hoon
    Jung, Ghap-Joong
    Kim, Min-Chan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (04) : 603 - 607
  • [33] High Rate of Pathologic Response after Concurrent Chemoradiation with Cisplatin and 5FU Followed by Surgery for Localized Esophageal Cancer
    Staal, E. Courrech
    Cats, A.
    Aleman, B.
    Jansen, E.
    Van Velthuysen, L.
    Boot, H.
    Van Coevorden, F.
    Van Sandick, J.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 66 - 66
  • [34] The clinical studies of weekly Taxol plus Cisplatin and continuous infusion of 5-FU in patients with advanced gastric cancer
    Jia, Chen
    Ling, Hang F.
    ANNALS OF ONCOLOGY, 2004, 15 : 234 - 234
  • [35] No improvement of treatment results of concurrent radiochemotherapy of cervical cancer with 5-FU compared to cisplatin
    Fietkau, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (06) : 356 - 357
  • [36] Measurements of 5-FU levels in plasma of patients with gastrointestinal cancer.
    Blaschke, Martina
    Cameron, Silke
    Blumberg, Jutta
    Wegner, Ulrike
    Ramadori, Giuliano
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [37] PROTRACTED INFUSION OF 5-FU WITH WEEKLY LOW-DOSE CISPLATIN AS 2ND-LINE THERAPY IN PATIENTS WITH METASTATIC COLORECTAL-CANCER WHO HAVE FAILED 5-FU MONOTHERAPY
    AHLGREN, JD
    TROCKI, O
    GULLO, JJ
    GOLDBERG, R
    MUIR, WA
    SISK, R
    SCHACTER, L
    CANCER INVESTIGATION, 1991, 9 (01) : 27 - 33
  • [38] 5-FU by protracted continuous infusion and radiation therapy in rectal cancer.
    Baena, JM
    Rueda, A
    Mateos, A
    Gómez, MJ
    Contreras, JA
    de las Peñas, MD
    Senra, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S79 - S79
  • [39] PHASE-II STUDY OF CISPLATIN, 5-FU, AND ALLOPURINOL IN ADVANCED ESOPHAGEAL CANCER
    DEBESI, P
    SILENI, VC
    SALVAGNO, L
    TREMOLADA, C
    CARTEI, G
    FOSSER, V
    PACCAGNELLA, A
    PERACCHIA, A
    FIORENTINO, M
    CANCER TREATMENT REPORTS, 1986, 70 (07): : 909 - 910
  • [40] Randomized phase II trial comparing gemcitabine/cisplatin-based chemoradiotherapy (CRT) to 5-FU-based CRT in patients with locally advanced pancreatic cancer.
    Wilkowski, R.
    Rau, H.
    Bruns, C.
    Wagner, A.
    Sauer, R.
    Hohenberger, W.
    Koelbl, O.
    Heinemann, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 188S - 188S
12345